xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

427

ICAR SINONASAL TUMORS

eds. Atlas of Tumor Pathology . 2nd series, Fascicle 25. Armed Forces Institute of Pathology; 1988:240-248. 1339. Hyams VJ. Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Morales AR, eds. Special Tumors of the Head and Neck . American Society of Clinical Pathologists; 1983:24-29. 1340. Van Gompel J, Giannini C, Olsen K, et al. Long-term outcome of esthesioneuroblastoma: Hyams grade predicts patient sur vival. J Neurol Surg B . 2012;73(05):331-336. https://doi.org/10. 1055/s-0032-1321512 1341. Malouf GG, Casiraghi O, Deutsch E, Guigay J, Temam S, Bourhis J. Low- and high-grade esthesioneuroblastomas dis play a distinct natural history and outcome. Eur J Cancer . 2013;49(6):1324-1334. https://doi.org/10.1016/j.ejca.2012.12.008 1342. Goshtasbi K, Abiri A, Abouzari M, et al. Hyams grading as a predictor of metastasis and overall survival in esthe sioneuroblastoma: a meta-analysis. Int Forum Allergy Rhinol . 2019;9(9):1054-1062. https://doi.org/10.1002/alr.22373 1343. Kane AJ, Sughrue ME, Rutkowski MJ, et al. Posttreatment prognosis of patients with esthesioneuroblastoma: clinical article. J Neurosurg . 2010;113(2):340-351. https://doi.org/10. 3171/2010.2.JNS091897 1344. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma— a clinical analysis of 17 cases. Cancer . 1976;37(3):1571-1576. https://doi.org/10.1002/1097-0142(197603)37:3 ⟨ 1571::AID CNCR2820370347 ⟩ 3.0.CO;2-L 1345. Ziai H, Yu E, Weinreb I, et al. Regional recurrences and Hyams grade in esthesioneuroblastoma. J Neurol Surg B Skull Base . 2021;82(06):608-614. https://doi.org/10.1055/s-0040-1715809 1346. Wolfe AR, Blakaj D, London N, et al. Clinical outcomes and multidisciplinary patterns of failure for olfactory neuroblas toma: the Ohio state experience. J Neurol Surg B Skull Base . 2020;81(03):287-294. https://doi.org/10.1055/s-0039-1692479 1347. Singh S, Singh L, Ranjan R, Singh MK, Thakar A, Sharma SC. Correlating the treatment outcome with tumor staging, grad ing, and various treatment modalities in patients with esthe sioneuroblastoma. South Asian J Cancer . 2019;08(02):124-126. https://doi.org/10.4103/sajc.sajc_273_18 1348. Marinelli J, Janus J, Van Gompel J, et al. Dural invasion pre dicts the laterality and development of neck metastases in esthesioneuroblastoma. J Neurol Surg B . 2018;79(05):495-500. https://doi.org/10.1055/s-0038-1625977 1349. Turri-Zanoni M, Maragliano R, Battaglia P, et al. The clin icopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: refinements in diag nostic criteria and impact of multimodal treatments on survival. Oral Oncol . 2017;74:21-29. https://doi.org/10.1016/j. oraloncology.2017.09.010 1350. Safi C, Spielman D, Otten M, et al. Treatment strategies and outcomes of pediatric esthesioneuroblastoma: a system atic review. Front Oncol . 2020;10:1247. https://doi.org/10.3389/ fonc.2020.01247 1351. McMillan RA, Van Gompel JJ, Link MJ, et al. Long-term oncologic outcomes in esthesioneuroblastoma: an institu tional experience of 143 patients. Int Forum Allergy Rhinol . 2022;12(12):1457-1467. https://doi.org/10.1002/alr.23007 1352. Klironomos G, Gonen L, Au K, et al. Endoscopic management of Esthesioneuroblastoma: our experience and review of the literature. J Clin Neurosci . 2018;58:117-123. https://doi.org/10. 1016/j.jocn.2018.09.011

sion. Head Neck . 2007;29(8):731-740. https://doi.org/10.1002/ hed.20564 1325. Lin N, Liu X, Zhang F, Pan Y, Qi M, Sha Y. Sinonasal synovial sarcoma: evaluation of the role of radiological and clinicopathological features in diagnosis. Clin Radiol . 2021;76(1):78.e1-78.e8. https://doi.org/10.1016/j.crad.2020.08. 007 1326. Saito S, Ozawa H, Ikari Y, et al. Synovial sarcoma of the max illary sinus: an extremely rare case with excellent response to chemotherapy. Onco Targets Ther . 2018;11:483-488. https://doi. org/10.2147/OTT.S151473 1327. Baranov E, McBride MJ, Bellizzi AM, et al. A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol . 2020;44(7):922-933. https://doi.org/10.1097/ PAS.0000000000001447 1328. Gil Z, Orr-Urtreger A, Voskoboinik N, Trejo-Leider L, Shomrat R, Fliss DM. Cytogenetic analysis of 101 skull base tumors. Head Neck . 2008;30(5):567-581. https://doi.org/10.1002/hed. 20741 1329. Terzic A, Bode B, Gratz KW, Stoeckli SJ. Prognostic factors for the malignant triton tumor of the head and neck. HeadNeck . 2009;31(5):679-688. https://doi.org/10.1002/hed.21051 1330. Vengaloor Thomas T, Abraham A, Bhanat E, et al. Malignant peripheral nerve sheath tumor of nasal cavity and paranasal sinus with 13 years of follow-up—a case report and review of literature. Clin Case Rep . 2019;7(11):2194-2201. https://doi.org/ 10.1002/ccr3.2465 1331. Nicolai P, Tomenzoli D, Berlucchi M, Facchetti F, Morassi L, Maroldi R. Malignant triton tumor of the ethmoid sinus and nasal cavity. Ann Otol Rhinol Laryngol . 2000;109(9):880-886. https://doi.org/10.1177/000348940010900918 1332. Kaur RP, Izumchenko E, Blakaj DM, et al. The genomics and epigenetics of olfactory neuroblastoma: a systematic review. Laryngoscope Investig Otolaryngol . 2021;6(4):721-728. https:// doi.org/10.1002/lio2.597 1333. Su SY, Bell D, Hanna EY. Esthesioneuroblastoma, neu roendocrine carcinoma, and sinonasal undifferentiated car cinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol . 2014;18(Supp. 2):S149-S156. https://doi.org/ 10.1055/s-0034-1390014 1334. Shah K, Perez-Ordóñez B. Neuroendocrine neoplasms of the sinonasal tract: neuroendocrine carcinomas and olfac tory neuroblastoma. Head and Neck Pathol . 2016;10(1):85-94. https://doi.org/10.1007/s12105-016-0696-7 1335. Berger MH, Lehrich BM, Yasaka TM, Fong BM, Hsu FPK, Kuan EC. Characteristics and overall survival in pediatric ver sus adult esthesioneuroblastoma: a population-based study. Int J Pediatr Otorhinolaryngol . 2021;144:110696. https://doi. org/10.1016/j.ijporl.2021.110696 1336. Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grad ing system. Curr Oncol Rep . 2015;17(1):423. https://doi.org/10. 1007/s11912-014-0423-z 1337. Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head and Neck Pathol . 2015;9(1):51-59. https://doi.org/10.1007/s12105-014-0547-3 1338. Hyams VJ, Batsakis JG, Michaels L. Tumors of the upper res piratory tract and ear. In: Hyams VJ, Batsakis JG, Michaels L,